Retiro De Equipo (Recall) de Device Recall Pentax Inc

Según U.S. Food and Drug Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en United States que fue producido por Pentax of America Inc.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • ID del evento
    75249
  • Clase de Riesgo del Evento
    Class 2
  • Número del evento
    Z-0757-2017
  • Fecha de inicio del evento
    2016-05-31
  • Estado del evento
    Open, Classified
  • País del evento
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Bronchoscope (flexible or rigid) - Product Code EOQ
  • Causa
    The eb-1970uk ultrasound video bronchoscope shipped between the clearance date of april 2014 and september 2015 contained the operation and reprocessing ifus that were in use prior to the 2014 clearance, and therefore did not include the cleared operation and reprocessing ifus.
  • Acción
    Pentax sent a US Urgent Field Correction letter to all affected customers with a field correction/field safety response form via USPS on May 31, 2016. The letter identified the product, the problem, and the action to be taken by the customer. Revised instructions were as follows: The instructions have been revised in the following manner: ¿ Operation IFU o Integrated all models of each family into the IFU o Modified the indications for use language to be consistent with similar products o Enhanced the explanation of the operation of the device o Revised and added cautions and warnings ¿ Reprocessing IFU o Included more specificity regarding reprocessing activities to aid in the proper method for reprocessing the endoscopes, including: ¿ number of brush and rinse steps, ¿ quantity of fluid volumes, ¿ use of additional text, figures, cautions, and warnings Identification of Affected Endoscope Models Table 1 provides an overview of the Affected Endoscope models, and the part number and revision of the historical and revised IFUs. The accompanying USB flash drive contains all the revised IFUs identified below. Please distribute only those IFUs which support the products owned by your facility. Table 1 Affected Models Historical Version of IFUs Revised IFUs EB-1970UK Ultrasound Video Bronchoscope Z870 Owners IFU S016_R02 Operator IFU S021_R04 Reprocessing IFU No.388_R01 Addendum No.392_R00 Addendum EB-70K series Video Bronchoscopes Z705 Operation IFU S015_R04 Operator IFU S020_R04 Reprocessing IFU No.388_R01 Addendum No.392_R00 Addendum Z706 Reprocessing IFU EB-75K series Video Bronchoscopes S003 Owners IFU Customers were instructed to ensure that user departments discard the prior versions of the Instructions for Use and ensure that all users read and carefully follow the revised Operation and Reprocessing IFUs to ensure the proper use and cleaning of the affected PENTAX endoscopes. Customers were advised to contact their PEN

Device

  • Modelo / Serial
    EB-1970UK
  • Clasificación del producto
  • Clase de dispositivo
    2
  • ¿Implante?
    No
  • Distribución
    Nationwide Distribution
  • Descripción del producto
    Ultrasound Video Bronchoscope || The EB-1970UK, Ultrasound Video Bronchoscope, is intended to provide optical visualization of, ultrasonic visualization of, and therapeutic access to, the Pulmonary Track including but not restricted to organs, tissues, and subsystem: Nasal Passage, Pharynx, Larynx, Trachea, Bronchial Tree (including access beyond the stem), and underlying areas. The instrument is introduced per orally when indications consistent with the requirement for procedure are observed in adult and pediatric patient populations.
  • Manufacturer

Manufacturer

  • Dirección del fabricante
    Pentax of America Inc, 3 Paragon Dr, Montvale NJ 07645-1782
  • Empresa matriz del fabricante (2017)
  • Source
    USFDA